157 related articles for article (PubMed ID: 31081536)
1. Significant variation in heart valve banking practice.
Zahra S; Galea G; Jashari R; Petit P; de By TMMH
Eur J Clin Microbiol Infect Dis; 2019 Aug; 38(8):1491-1498. PubMed ID: 31081536
[TBL] [Abstract][Full Text] [Related]
2. Validation of microbiological testing in cardiovascular tissue establishments: results of a second international quality-round trial.
Zahra S; Galea G; Jashari R; Petit P; de By TMMH
Eur J Clin Microbiol Infect Dis; 2019 Aug; 38(8):1481-1490. PubMed ID: 31081537
[TBL] [Abstract][Full Text] [Related]
3. Quality control in homograft valve processing: when to screen for microbiological contamination?
Soo A; Healy DG; El-Bashier H; Shaw S; Wood AE
Cell Tissue Bank; 2011 Aug; 12(3):185-90. PubMed ID: 20490931
[TBL] [Abstract][Full Text] [Related]
4. Banking of cryopreserved heart valves in Europe: assessment of a 10-year operation in the European Homograft Bank (EHB).
Goffin YA; Van Hoeck B; Jashari R; Soots G; Kalmar P
J Heart Valve Dis; 2000 Mar; 9(2):207-14. PubMed ID: 10772038
[TBL] [Abstract][Full Text] [Related]
5. Mycobacteria and allograft heart valve banking: an international survey.
Warwick RM; Magee JG; Leeming JP; Graham JC; Hannan MM; Chadwick M; Crook DW; Yearsley CP; Rayner A; Parker R
J Hosp Infect; 2008 Mar; 68(3):255-61. PubMed ID: 18294727
[TBL] [Abstract][Full Text] [Related]
6. Validation of microbiological testing in cardiovascular tissue banks: results of a quality round trial.
de By TMMH; McDonald C; Süßner S; Davies J; Heng WL; Jashari R; Bogers AJJC; Petit P
Eur J Cardiothorac Surg; 2017 Nov; 52(5):895-900. PubMed ID: 28605496
[TBL] [Abstract][Full Text] [Related]
7. Factors affecting the yield of cardiac valve allografts from living unrelated donors.
Hunt CJ; Caffrey EA; Large SR
Eur J Cardiothorac Surg; 1998 Jan; 13(1):71-7. PubMed ID: 9504733
[TBL] [Abstract][Full Text] [Related]
8. Microbiological examination of donated human cardiac tissue in heart valve banking.
van Kats JP; van Tricht C; van Dijk A; van der Schans M; van den Bogaerdt A; Petit PL; Bogers AJ
Eur J Cardiothorac Surg; 2010 Jan; 37(1):163-9. PubMed ID: 19709896
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular tissue banking in the non-cadaveric setting: ten-year experience of a university hospital-based bank with active organ donation program.
Mestres CA; Agusti E; Martinez A; Cabrer C; Manyalich M; Cartaña R; Pomar JL
J Heart Valve Dis; 2000 Jul; 9(4):523-9. PubMed ID: 10947045
[TBL] [Abstract][Full Text] [Related]
10. Banking cryopreserved heart valves in Europe: assessment of a 5-year operation in an international tissue bank in Brussels.
Goffin Y; Grandmougin D; Van Hoeck B
Eur J Cardiothorac Surg; 1996; 10(7):505-12. PubMed ID: 8855421
[TBL] [Abstract][Full Text] [Related]
11. Microbiological analysis of cryopreserved human heart valves after storage: a survey of 3 banks in Spain.
Villalba R; Mirabet V; Rendal E; González AI; Solves P; Andión C; Gómez Villagrán JL
Cell Tissue Bank; 2009 Nov; 10(4):345-9. PubMed ID: 19452264
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of decontamination process of heart valve and artery tissues in European Homograft Bank (EHB): a retrospective study of 1,055 cases.
Fan YD; Van Hoeck B; Holovska V; Jashari R
Cell Tissue Bank; 2012 Jun; 13(2):297-304. PubMed ID: 21512894
[TBL] [Abstract][Full Text] [Related]
13. Microbiologyc control in human heart valves.
Peruzzo AM; da Costa FD; Abrahão WM
Arq Bras Cardiol; 2006 Dec; 87(6):778-82. PubMed ID: 17262117
[TBL] [Abstract][Full Text] [Related]
14. In vitro susceptibility of high virulence microorganisms isolated in heart valve banking.
Villalba R; Solis F; Fornés G; Jimenez A; Eisman M; González AI; Linares MJ; Casal M; Gómez Villagrán JL
Cell Tissue Bank; 2012 Aug; 13(3):441-5. PubMed ID: 22618487
[TBL] [Abstract][Full Text] [Related]
15. Heart valve allograft decontamination with antibiotics: impact of the temperature of incubation on efficacy.
Germain M; Thibault L; Jacques A; Tremblay J; Bourgeois R
Cell Tissue Bank; 2010 May; 11(2):197-204. PubMed ID: 20390362
[TBL] [Abstract][Full Text] [Related]
16. Banking of the human heart valves and the arteries at the European homograft bank (EHB)--overview of a 14-year activity in this International Association in Brussels.
Jashari R; Van Hoeck B; Tabaku M; Vanderkelen A
Cell Tissue Bank; 2004; 5(4):239-51. PubMed ID: 15591827
[TBL] [Abstract][Full Text] [Related]
17. Decontamination of heart valve and arterial allografts in the European Homograft Bank (EHB): comparison of two different antibiotic cocktails in low temperature conditions.
Jashari R; Tabaku M; Van Hoeck B; Cochéz C; Callant M; Vanderkelen A
Cell Tissue Bank; 2007; 8(4):247-55. PubMed ID: 17440832
[TBL] [Abstract][Full Text] [Related]
18. Bacterial contamination of tissue allografts - experiences of the donor tissue bank of Victoria.
Ireland L; Spelman D
Cell Tissue Bank; 2005; 6(3):181-9. PubMed ID: 16151958
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular tissue banking in Europe.
de By TM; Parker R; Delmo Walter EM; Hetzer R
HSR Proc Intensive Care Cardiovasc Anesth; 2012; 4(4):251-60. PubMed ID: 23439733
[TBL] [Abstract][Full Text] [Related]
20. Advantages and challenges in processing and quality control of decellularized heart valves.
Lux M; Haller R; Giere B; Lindner B; Harder M; Mastrobuoni S; Jashari R
Cell Tissue Bank; 2024 Mar; 25(1):43-53. PubMed ID: 37138137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
